J G Csernansky|C A Csernansky - JoVE Visualize

Showing results (41-50 of 121) with videos related to

Pageof 13

Sort By:

Psychopharmacology|January 1, 1983

Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatientsJ G Csernansky, J Kaplan, C A Holman, et al.

Epilepsia|May 1, 1990

Psychopathology and limbic epilepsy: relationship to seizure variables and neuropsychological functionJ G Csernansky, D B Leiderman, M Mandabach, et al.

Life Sciences|January 1, 1990

Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administrationJ G Csernansky, D E Barnes, E P Bellows, et al.

Psychopharmacology Bulletin|January 1, 1992

Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decreaseJ W Newcomer, S J Riney, S Vinogradov, et al.

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 15, 1998

Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunctionY I Sheline, K Miller, M E Bardgett, et al.

Journal of Clinical Psychopharmacology|December 1, 1984

Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label studyJ G Csernansky, L Lombrozo, G D Gulevich, et al.

Psychiatric Services (Washington, D.C.)|August 26, 1998

Predicting length of stay in an acute psychiatric hospitalD A Huntley, D W Cho, J Christman, et al.

Psychopharmacology|March 14, 1998

The effects of kainic acid lesions on locomotor responses to haloperidol and clozapineM E Bardgett, J L Jackson, B M Taylor, et al.

Psychiatry Research|May 1, 1989

Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patientsW O Faustman, J A Moses, J G Csernansky, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 1995

Platelet binding characteristics distinguish placebo responders from nonresponders in depressionY I Sheline, K J Black, M E Bardgett, et al.

Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:

Pageof 13

Psychopharmacology|January 1, 1983

Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatientsJ G Csernansky, J Kaplan, C A Holman, et al.

Epilepsia|May 1, 1990

Psychopathology and limbic epilepsy: relationship to seizure variables and neuropsychological functionJ G Csernansky, D B Leiderman, M Mandabach, et al.

Life Sciences|January 1, 1990

Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administrationJ G Csernansky, D E Barnes, E P Bellows, et al.

Psychopharmacology Bulletin|January 1, 1992

Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decreaseJ W Newcomer, S J Riney, S Vinogradov, et al.

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 15, 1998

Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunctionY I Sheline, K Miller, M E Bardgett, et al.

Journal of Clinical Psychopharmacology|December 1, 1984

Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label studyJ G Csernansky, L Lombrozo, G D Gulevich, et al.

Psychiatric Services (Washington, D.C.)|August 26, 1998

Predicting length of stay in an acute psychiatric hospitalD A Huntley, D W Cho, J Christman, et al.

Psychopharmacology|March 14, 1998

The effects of kainic acid lesions on locomotor responses to haloperidol and clozapineM E Bardgett, J L Jackson, B M Taylor, et al.

Psychiatry Research|May 1, 1989

Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patientsW O Faustman, J A Moses, J G Csernansky, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 1995

Platelet binding characteristics distinguish placebo responders from nonresponders in depressionY I Sheline, K J Black, M E Bardgett, et al.

Pageof 13